Product Description
| Brand |
Medtronic |
| Stent Diameter (mm) |
2.75 |
| Stent Length (mm) |
15 & 18 |
| CAT No |
RONYX27515W & RONYX27518W |
| Catheter Length |
300 cm |
Resolute Onyx is a drug-eluting stent (DES) that's different by design, optimised for complex PCI, and proven safe and effective in real-world, high bleeding risk patients on 1-month dual antiplatelet therapy (DAPT). Resolute Onyx drug-eluting stent (DES) offers flexibility, conformability, a 2.0-5.0 mm size matrix, and is indicated for high bleeding risk patients and labeled for one-month DAPT.
Advanced Drug-Eluting TechnologyThe Resolute Onyx DES employs a unique BioLinx polymer matrix to deliver zotarolimus with precision, reducing the risk of arterial restenosis. This advanced coating technology ensures sustained drug release directly at the lesion site, enhancing long-term patency.
Exceptional Deliverability and VisibilityFeaturing a thin strut design with a platinum-iridium core, the Resolute Onyx stent is ultra-lightweight and highly radiopaque. These features support smooth navigation through coronary vessels and allow for exact positioning, even in complex procedures.
Versatile and Compatible SystemThis stent system is designed for ease of use, compatible with 0.014'' guidewires and requiring a minimum 5 Fr (1.67 mm) guide catheter. With a variety of length options (8-34 mm), it accommodates diverse lesion lengths to personalize patient care.
FAQ's of Medtronic Resolute Onyx DES Drug-eluting Stent (SD 2.75):
Q: How is the Medtronic Resolute Onyx DES deployed during a PCI procedure?
A: The stent is manually delivered via a balloon-expandable, rapid-exchange catheter system. It is inserted through a compatible 5 Fr guide catheter over a 0.014'' guidewire and expanded at the lesion site during the procedure.
Q: What size options are available for the Resolute Onyx DES (2.75 mm diameter)?
A: The stent is available in lengths ranging from 8 mm to 34 mm, allowing clinicians to select the most appropriate length based on the characteristics of the target lesion.
Q: When should the Resolute Onyx DES be used?
A: This stent is indicated for patients with de novo coronary artery lesions requiring percutaneous coronary intervention (PCI). It delivers controlled zotarolimus release to reduce restenosis risk following angioplasty.
Q: Where should the Resolute Onyx DES be stored prior to use?
A: Store the stent in its original blister packaging at room temperature. Ensure it is kept away from direct sunlight and only opened immediately before use to maintain sterility.
Q: What are the main benefits of the Resolute Onyx DES?
A: Key advantages include enhanced deliverability, thin strut design for small vessel compatibility, high radiopacity for precise placement, and reduced restenosis rates due to controlled drug release.
Q: How does the stent maintain its sterilization and shelf life?
A: The stent is sterilized using EO gas and is single-use disposable. The expiration date is indicated on the packaging, with a typical shelf life of 2-3 years if stored properly.
Q: What steps are involved in using the Resolute Onyx DES during treatment?
A: The process involves preparing the lesion site, advancing the stent over a 0.014'' guidewire using a rapid-exchange delivery catheter, deploying it at the targeted lesion, and removing the delivery system following successful placement.